InvestorsHub Logo
Followers 137
Posts 22808
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 01/28/2017 12:28:25 PM

Saturday, January 28, 2017 12:28:25 PM

Post# of 807
Oxford BioMedica and Immune Design's LV305 trial in progress

http://www.immunedesign.com/wp-content/uploads/2016/06/LV305-ASCO-poster-2016-final-31May2016-v01.pdf

A Phase 1, Open-Label Clinical Trial Evaluating the Safety, Tolerability and Immunogenicity of Intradermally Administered ID-LV305 in Patients with Locally Advanced or Metastatic Cancer Expressing NY-ESO-1

https://clinicaltrials.gov/ct2/show/NCT02122861?term=LV305&rank=1

http://osp.od.nih.gov/sites/default/files/6_1266_ID-LV305_ImmuneDesign_0.pdf

Good luck and GOD bless,

George